Thursday, November 30, 2023
In compliance with EBAC/EACCME guidelines, all speakers/chairpersons participating in this programme have disclosed potential conflicts of interest that might cause a bias in the presentations. The Organising Committee is responsible for ensuring that all potential conflicts of interest relevant to the programme are declared to the audience prior to the CME activities.
Professor of Cardiology, Department of Cardiovascular Science, University of Sheffield; Academic Director and Honorary Consultant in Cardiology, The Cardiology and Cardiothoracic Surgery Directorate, Sheffield Teaching Hospitals, Sheffield, United Kingdom
This educational activity is intended for an international audience of non-US healthcare professionals, specifically interventional cardiologists, general cardiologists, emergency department physicians, internists, and primary care physicians involved in the management of patients with acute coronary syndromes (ACS).
The goal of this activity is to apply the current European Society of Cardiology guidelines for the use of dual antiplatelet therapy for the secondary prevention of myocardial infarction and the use of evidence-based therapies for comorbid cardiovascular (CV) disease with the goal of improving the clinical care of patients with ACS.
Upon completion of this activity, participants will be able to:
In compliance with EBAC/EACCME guidelines, all speakers/chairpersons participating in this programme have disclosed potential conflicts of interest that might cause a bias in the presentations. The Organising Committee is responsible for ensuring that all potential conflicts of interest relevant to the programme are declared to the audience prior to the CME activities.
Professor of Cardiology, Department of Cardiovascular Science, University of Sheffield; Academic Director and Honorary Consultant in Cardiology, The Cardiology and Cardiothoracic Surgery Directorate, Sheffield Teaching Hospitals, Sheffield, United Kingdom
The Internet Course “Preventing Recurrent CV Events: Role of Antithrombotic Therapy” is accredited by the European Board for Accreditation in Cardiology (EBAC) for 1.00 hours of External CME credits.
Each participant should claim only those hours of credit that have actually been spent in the educational activity. EBAC works according to the quality standards of the European Accreditation Council for Continuing Medical Education (EACCME), which is an institution of the European Union of Medical Specialists (UEMS).
For questions regarding the content of this activity, contact the accredited provider for this CME/CE activity noted above. For technical assistance, contact [email protected]
There are no fees for participating in or receiving credit for this online educational activity. For information on applicability and acceptance of continuing education credit for this activity, please consult your professional licensing board.
This activity is designed to be completed within the time designated on the title page; physicians should claim only those credits that reflect the time actually spent in the activity. To successfully earn credit, participants must complete the activity online during the valid credit period that is noted on the title page.
Follow these steps to earn CME/CE credit*:
You may now view or print the certificate from your CME/CE Tracker. You may print the certificate but you cannot alter it.
Credits will be tallied in your CME/CE Tracker and archived for 6 years; at any point within this time period you can print
out the tally as well as the certificates by accessing "Edit Your Profile" at the top of your Medscape homepage.
*The credit that you receive is based on your user profile.
CME Released: 6/10/2016
Valid for credit through: 6/10/2017, 11:59 PM EST
processing....
ABI = ankle brachial index
ACS = acute coronary syndrome
CHD = coronary heart disease
CI = confidence interval
CV = cardiovascular
DAPT = dual antiplatelet therapy
DES = drug-eluting stent
ECG-LVH = electrocardiographic left ventricular hypertrophy
EMA = European Medicines Agency
ESC = European Society of Cardiology
FDA = US Food and Drug Administration
HR = hazard ratio
ICH = intracranial hemorrhage
IMT = intima-media thickness
LDL-C = low-density lipoprotein cholesterol
MACE = major adverse cardiovascular events
MI = myocardial infarction
NS = not significant
NSTEMI = non-ST-segment elevation myocardial infarction
TIMI = Thrombosis in Myocardial Infarction
| « Return to: Preventing Recurrent CV Events: Role of Antithrombotic Therapy |
